The store will not work correctly when cookies are disabled.
2-(4-methoxyphenyl)sulfonylisoindoline-1,3-dione
ID: ALA4868200
PubChem CID: 86167049
Max Phase: Preclinical
Molecular Formula: C15H11NO5S
Molecular Weight: 317.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(S(=O)(=O)N2C(=O)c3ccccc3C2=O)cc1
Standard InChI: InChI=1S/C15H11NO5S/c1-21-10-6-8-11(9-7-10)22(19,20)16-14(17)12-4-2-3-5-13(12)15(16)18/h2-9H,1H3
Standard InChI Key: FPVSGYOODONUGT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
4.7752 -17.3798 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9898 -18.1722 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.5688 -17.5901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9580 -19.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2123 -18.4273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5494 -17.9452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5481 -17.1280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4375 -19.8657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5964 -18.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4199 -19.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0257 -20.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8075 -19.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9800 -19.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3728 -18.4709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4130 -20.3730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2404 -21.1718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1421 -19.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8897 -18.4244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0903 -18.2547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5424 -18.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7996 -19.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5984 -19.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
17 4 1 0
4 5 1 0
5 6 1 0
6 18 1 0
6 7 2 0
4 8 2 0
5 2 1 0
2 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.32 | Molecular Weight (Monoisotopic): 317.0358 | AlogP: 1.68 | #Rotatable Bonds: 3 |
Polar Surface Area: 80.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.13 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -0.80 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |